Dr. Jay Chaplin

Cancer drug designer and patient educator

Oncology and cancer treatment education

2Episodes

77 minAnalysed

2Topics

Last reviewed: Jul 12, 2026·Credential: Scientist and cancer drug designer·First indexed: Jul 12, 2026

About the expert

Focus: Cancer biology, drug design, and supplements

Dr. Jay Chaplin is a scientist and cancer drug designer and the host of Elevating Cancer Treatment. He creates evidence-based content to help patients understand oncology research and treatment options. His work covers chemotherapy, immunotherapy, and complementary approaches.

Why this matters

Cancer drug designer (a PhD scientist, not a physician) who explains the biology of supplements and treatments and is developing an immunotherapy. Strongest on mechanisms and on the real risks of supplement-treatment interactions; goes beyond established evidence with specific protocols for which cancers benefit and how to dose curcumin, and promotes a paid consulting service. Treat the mechanisms as informative and the specific protocols as his interpretation, to check with an oncologist.

Filter by species:

Topics covered

Curcumin Cancer Immunotherapy

Episodes with Dr. Jay Chaplin

Curcumin and cancer: could it interfere with your treatment?

Curcumin, the active compound in turmeric, is not simply safe or helpful during cancer. It may influence cancer biology through pathways such as NF-κB, but whether that helps or hinders treatment depends on the cancer and therapy and is incompletely understood. Absorption is poor, and the black-pepper additive piperine can raise the risk of drug interactions. The safe path is to coordinate any supplement with your oncologist.

15 minHuman

Explore episode →

Why does immunotherapy work for some cancers and not others?

Whether immunotherapy works depends on your tumour's biology, not on whether the cancer is 'a melanoma' or 'a breast cancer'. Three things must line up: an immune cell that recognises the cancer, enough signal to switch it on, and the brakes released. The speaker argues chemotherapy and immunotherapy pull against each other when given together, which is a real research question, but one where approved combinations still improved survival.

62 minHuman

Explore episode →